nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—ABCB11—Dexamethasone—ulcerative colitis	0.114	0.227	CbGbCtD
Bosentan—CYP3A4—Budesonide—ulcerative colitis	0.0695	0.138	CbGbCtD
Bosentan—CYP2C9—Nicotine—ulcerative colitis	0.052	0.103	CbGbCtD
Bosentan—CYP2C9—Cholecalciferol—ulcerative colitis	0.0467	0.0926	CbGbCtD
Bosentan—ABCB11—bile duct—ulcerative colitis	0.0433	0.481	CbGeAlD
Bosentan—ABCB11—bile—ulcerative colitis	0.0333	0.369	CbGeAlD
Bosentan—CYP3A4—Methylprednisolone—ulcerative colitis	0.031	0.0616	CbGbCtD
Bosentan—CYP3A4—Nicotine—ulcerative colitis	0.0302	0.06	CbGbCtD
Bosentan—CYP3A4—Cholecalciferol—ulcerative colitis	0.0271	0.0538	CbGbCtD
Bosentan—CYP3A4—Triamcinolone—ulcerative colitis	0.0235	0.0467	CbGbCtD
Bosentan—CYP2C9—Dexamethasone—ulcerative colitis	0.0202	0.04	CbGbCtD
Bosentan—CYP3A4—Betamethasone—ulcerative colitis	0.0202	0.04	CbGbCtD
Bosentan—CYP3A4—Prednisolone—ulcerative colitis	0.0199	0.0395	CbGbCtD
Bosentan—CYP3A4—Hydrocortisone—ulcerative colitis	0.0189	0.0374	CbGbCtD
Bosentan—CYP3A4—Prednisone—ulcerative colitis	0.0188	0.0373	CbGbCtD
Bosentan—CYP3A4—Dexamethasone—ulcerative colitis	0.0117	0.0233	CbGbCtD
Bosentan—ABCB11—digestive system—ulcerative colitis	0.00364	0.0404	CbGeAlD
Bosentan—EDNRB—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.00353	0.0345	CbGpPWpGaD
Bosentan—EDNRB—Prostaglandin Synthesis and Regulation—PTGS1—ulcerative colitis	0.00347	0.034	CbGpPWpGaD
Bosentan—EDNRB—liver—ulcerative colitis	0.00336	0.0372	CbGeAlD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.00272	0.0266	CbGpPWpGaD
Bosentan—ABCB11—liver—ulcerative colitis	0.00271	0.0301	CbGeAlD
Bosentan—EDNRB—Peptide GPCRs—CXCR1—ulcerative colitis	0.00264	0.0259	CbGpPWpGaD
Bosentan—EDNRA—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.00252	0.0247	CbGpPWpGaD
Bosentan—EDNRA—Prostaglandin Synthesis and Regulation—PTGS1—ulcerative colitis	0.00249	0.0243	CbGpPWpGaD
Bosentan—EDNRB—Endothelins—GNA12—ulcerative colitis	0.00248	0.0243	CbGpPWpGaD
Bosentan—EDNRB—Peptide GPCRs—CXCR2—ulcerative colitis	0.00207	0.0202	CbGpPWpGaD
Bosentan—EDNRB—Peptide GPCRs—CCR6—ulcerative colitis	0.00195	0.019	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.00194	0.019	CbGpPWpGaD
Bosentan—EDNRA—Peptide GPCRs—CXCR1—ulcerative colitis	0.00189	0.0185	CbGpPWpGaD
Bosentan—EDNRA—Endothelins—GNA12—ulcerative colitis	0.00178	0.0174	CbGpPWpGaD
Bosentan—ABCB11—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.00177	0.0173	CbGpPWpGaD
Bosentan—ABCB11—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.00176	0.0173	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Other—CXCR1—ulcerative colitis	0.0016	0.0157	CbGpPWpGaD
Bosentan—EDNRA—Peptide GPCRs—CXCR2—ulcerative colitis	0.00148	0.0145	CbGpPWpGaD
Bosentan—EDNRA—Peptide GPCRs—CCR6—ulcerative colitis	0.00139	0.0136	CbGpPWpGaD
Bosentan—EDNRB—Prostaglandin Synthesis and Regulation—PTGS2—ulcerative colitis	0.00133	0.013	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Other—CXCR2—ulcerative colitis	0.00126	0.0123	CbGpPWpGaD
Bosentan—EDNRB—Endothelins—ADCY5—ulcerative colitis	0.00125	0.0123	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CXCR1—ulcerative colitis	0.00124	0.0122	CbGpPWpGaD
Bosentan—CYP2C9—digestive system—ulcerative colitis	0.00123	0.0137	CbGeAlD
Bosentan—ABCB11—Recycling of bile acids and salts—ALB—ulcerative colitis	0.00116	0.0114	CbGpPWpGaD
Bosentan—EDNRB—Endothelins—MMP1—ulcerative colitis	0.00111	0.0109	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CCL20—ulcerative colitis	0.00109	0.0107	CbGpPWpGaD
Bosentan—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.00101	0.00993	CbGpPWpGaD
Bosentan—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.00101	0.00991	CbGpPWpGaD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000974	0.00953	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.000973	0.00952	CbGpPWpGaD
Bosentan—EDNRA—Prostaglandin Synthesis and Regulation—PTGS2—ulcerative colitis	0.000953	0.00932	CbGpPWpGaD
Bosentan—CYP3A4—digestive system—ulcerative colitis	0.00094	0.0104	CbGeAlD
Bosentan—CYP2C9—liver—ulcerative colitis	0.000918	0.0102	CbGeAlD
Bosentan—EDNRB—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.000915	0.00895	CbGpPWpGaD
Bosentan—EDNRA—Endothelins—ADCY5—ulcerative colitis	0.000897	0.00878	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CXCR1—ulcerative colitis	0.00089	0.00871	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000834	0.00816	CbGpPWpGaD
Bosentan—EDNRA—Endothelins—MMP1—ulcerative colitis	0.000794	0.00777	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Other—ADRB2—ulcerative colitis	0.000787	0.0077	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CCL20—ulcerative colitis	0.000782	0.00765	CbGpPWpGaD
Bosentan—EDNRB—Endothelins—JAK2—ulcerative colitis	0.000781	0.00764	CbGpPWpGaD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000762	0.00746	CbGpPWpGaD
Bosentan—EDNRB—G alpha (q) signalling events—GHRL—ulcerative colitis	0.000747	0.00731	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.000738	0.00722	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000732	0.00717	CbGpPWpGaD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000716	0.00701	CbGpPWpGaD
Bosentan—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000711	0.00696	CbGpPWpGaD
Bosentan—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000706	0.00691	CbGpPWpGaD
Bosentan—CYP3A4—liver—ulcerative colitis	0.0007	0.00777	CbGeAlD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000697	0.00682	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.000697	0.00682	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.000668	0.00654	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.000655	0.00641	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000653	0.00639	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CXCR1—ulcerative colitis	0.000635	0.00622	CbGpPWpGaD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000631	0.00617	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000614	0.00601	CbGpPWpGaD
Bosentan—ABCB11—Bile acid and bile salt metabolism—ALB—ulcerative colitis	0.000607	0.00593	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000597	0.00584	CbGpPWpGaD
Bosentan—EDNRA—Endothelins—JAK2—ulcerative colitis	0.000559	0.00547	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CCL20—ulcerative colitis	0.000558	0.00546	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000545	0.00534	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.00054	0.00529	CbGpPWpGaD
Bosentan—EDNRA—G alpha (q) signalling events—GHRL—ulcerative colitis	0.000535	0.00523	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.000528	0.00516	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000524	0.00513	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000513	0.00502	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CXCR2—ulcerative colitis	0.000497	0.00486	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000495	0.00484	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.000478	0.00468	CbGpPWpGaD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000478	0.00468	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CCR6—ulcerative colitis	0.000467	0.00457	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000467	0.00457	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CXCR1—ulcerative colitis	0.000455	0.00445	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000451	0.00442	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000439	0.0043	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—PTGER4—ulcerative colitis	0.000412	0.00403	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.00041	0.00401	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CCL20—ulcerative colitis	0.000399	0.00391	CbGpPWpGaD
Bosentan—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.000389	0.00381	CbGpPWpGaD
Bosentan—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000388	0.0038	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000387	0.00378	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—GHRL—ulcerative colitis	0.000377	0.00369	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000359	0.00351	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CXCR2—ulcerative colitis	0.000356	0.00348	CbGpPWpGaD
Bosentan—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000356	0.00348	CbGpPWpGaD
Bosentan—CYP2C9—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000355	0.00348	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000354	0.00346	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000342	0.00335	CbGpPWpGaD
Bosentan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000339	0.00332	CbGpPWpGaD
Bosentan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000338	0.00331	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CCR6—ulcerative colitis	0.000335	0.00327	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CXCR1—ulcerative colitis	0.000326	0.00319	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CCL20—ulcerative colitis	0.000315	0.00308	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—ADRB2—ulcerative colitis	0.000312	0.00305	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—GNA12—ulcerative colitis	0.000296	0.0029	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.000295	0.00289	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—PTGER4—ulcerative colitis	0.000295	0.00288	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000293	0.00287	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000293	0.00286	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CCL20—ulcerative colitis	0.000286	0.0028	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000281	0.00275	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—GHRL—ulcerative colitis	0.00027	0.00264	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—GNA12—ulcerative colitis	0.000269	0.00263	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CCR6—ulcerative colitis	0.000264	0.00258	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000257	0.00251	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CXCR2—ulcerative colitis	0.000255	0.0025	CbGpPWpGaD
Bosentan—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000249	0.00244	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CCR6—ulcerative colitis	0.00024	0.00235	CbGpPWpGaD
Bosentan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000236	0.00231	CbGpPWpGaD
Bosentan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000235	0.0023	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SEL1L—ulcerative colitis	0.000234	0.00229	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CXCR1—ulcerative colitis	0.000233	0.00228	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000233	0.00228	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CCL20—ulcerative colitis	0.000226	0.00221	CbGpPWpGaD
Bosentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000223	0.00219	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—ADRB2—ulcerative colitis	0.000223	0.00218	CbGpPWpGaD
Bosentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000223	0.00218	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—GHRL—ulcerative colitis	0.000213	0.00208	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—GNA12—ulcerative colitis	0.000212	0.00208	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—PTGER4—ulcerative colitis	0.000211	0.00207	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.000211	0.00206	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000209	0.00205	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CCL20—ulcerative colitis	0.000205	0.002	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000201	0.00197	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000198	0.00194	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—GHRL—ulcerative colitis	0.000193	0.00189	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—GNA12—ulcerative colitis	0.000193	0.00188	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CXCR1—ulcerative colitis	0.000193	0.00188	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CCR6—ulcerative colitis	0.000189	0.00185	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CALM3—ulcerative colitis	0.000187	0.00183	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CXCR2—ulcerative colitis	0.000183	0.00179	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000176	0.00172	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CCR6—ulcerative colitis	0.000172	0.00168	CbGpPWpGaD
Bosentan—Vertigo—Triamcinolone—ulcerative colitis	0.000171	0.000563	CcSEcCtD
Bosentan—Hypersensitivity—Mesalazine—ulcerative colitis	0.000171	0.000563	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000171	0.000563	CcSEcCtD
Bosentan—Syncope—Triamcinolone—ulcerative colitis	0.000171	0.000562	CcSEcCtD
Bosentan—Vertigo—Methylprednisolone—ulcerative colitis	0.000171	0.000562	CcSEcCtD
Bosentan—Syncope—Methylprednisolone—ulcerative colitis	0.00017	0.000561	CcSEcCtD
Bosentan—Discomfort—Hydrocortisone—ulcerative colitis	0.00017	0.00056	CcSEcCtD
Bosentan—Nausea—Budesonide—ulcerative colitis	0.000169	0.000558	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—CCL20—ulcerative colitis	0.000169	0.00165	CbGpPWpGaD
Bosentan—Oedema—Prednisolone—ulcerative colitis	0.000169	0.000556	CcSEcCtD
Bosentan—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000169	0.000556	CcSEcCtD
Bosentan—Dizziness—Azathioprine—ulcerative colitis	0.000168	0.000554	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—SEL1L—ulcerative colitis	0.000167	0.00164	CbGpPWpGaD
Bosentan—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000167	0.000551	CcSEcCtD
Bosentan—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000167	0.000549	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000166	0.00163	CbGpPWpGaD
Bosentan—Asthenia—Mesalazine—ulcerative colitis	0.000166	0.000548	CcSEcCtD
Bosentan—Shock—Prednisolone—ulcerative colitis	0.000166	0.000547	CcSEcCtD
Bosentan—Cough—Triamcinolone—ulcerative colitis	0.000166	0.000547	CcSEcCtD
Bosentan—Oedema—Hydrocortisone—ulcerative colitis	0.000165	0.000543	CcSEcCtD
Bosentan—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000165	0.000543	CcSEcCtD
Bosentan—Tachycardia—Prednisolone—ulcerative colitis	0.000165	0.000543	CcSEcCtD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000164	0.00161	CbGpPWpGaD
Bosentan—Pruritus—Mesalazine—ulcerative colitis	0.000164	0.00054	CcSEcCtD
Bosentan—Infection—Hydrocortisone—ulcerative colitis	0.000164	0.000539	CcSEcCtD
Bosentan—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000163	0.000537	CcSEcCtD
Bosentan—ABCB11—Metabolism—CHP1—ulcerative colitis	0.000162	0.00159	CbGpPWpGaD
Bosentan—Shock—Hydrocortisone—ulcerative colitis	0.000162	0.000534	CcSEcCtD
Bosentan—Vomiting—Azathioprine—ulcerative colitis	0.000162	0.000533	CcSEcCtD
Bosentan—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000162	0.000533	CcSEcCtD
Bosentan—Arthralgia—Methylprednisolone—ulcerative colitis	0.000162	0.000532	CcSEcCtD
Bosentan—Eye disorder—Prednisone—ulcerative colitis	0.000161	0.000531	CcSEcCtD
Bosentan—Anxiety—Methylprednisolone—ulcerative colitis	0.000161	0.00053	CcSEcCtD
Bosentan—Tachycardia—Hydrocortisone—ulcerative colitis	0.000161	0.00053	CcSEcCtD
Bosentan—Rash—Azathioprine—ulcerative colitis	0.00016	0.000529	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.00016	0.000529	CcSEcCtD
Bosentan—Dermatitis—Azathioprine—ulcerative colitis	0.00016	0.000528	CcSEcCtD
Bosentan—Flushing—Prednisone—ulcerative colitis	0.00016	0.000528	CcSEcCtD
Bosentan—Skin disorder—Hydrocortisone—ulcerative colitis	0.00016	0.000527	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—ADRB2—ulcerative colitis	0.00016	0.00157	CbGpPWpGaD
Bosentan—Discomfort—Triamcinolone—ulcerative colitis	0.00016	0.000527	CcSEcCtD
Bosentan—Discomfort—Methylprednisolone—ulcerative colitis	0.00016	0.000526	CcSEcCtD
Bosentan—Headache—Azathioprine—ulcerative colitis	0.000159	0.000525	CcSEcCtD
Bosentan—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000159	0.000525	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—GNA12—ulcerative colitis	0.000159	0.00156	CbGpPWpGaD
Bosentan—Diarrhoea—Mesalazine—ulcerative colitis	0.000159	0.000522	CcSEcCtD
Bosentan—Dry mouth—Triamcinolone—ulcerative colitis	0.000158	0.000522	CcSEcCtD
Bosentan—Angioedema—Betamethasone—ulcerative colitis	0.000158	0.000519	CcSEcCtD
Bosentan—Angioedema—Dexamethasone—ulcerative colitis	0.000158	0.000519	CcSEcCtD
Bosentan—Anorexia—Hydrocortisone—ulcerative colitis	0.000157	0.000518	CcSEcCtD
Bosentan—Angiopathy—Prednisone—ulcerative colitis	0.000157	0.000516	CcSEcCtD
Bosentan—Immune system disorder—Prednisone—ulcerative colitis	0.000156	0.000514	CcSEcCtD
Bosentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000155	0.00152	CbGpPWpGaD
Bosentan—Oedema—Triamcinolone—ulcerative colitis	0.000155	0.000511	CcSEcCtD
Bosentan—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000155	0.000511	CcSEcCtD
Bosentan—Vertigo—Betamethasone—ulcerative colitis	0.000155	0.000511	CcSEcCtD
Bosentan—Vertigo—Dexamethasone—ulcerative colitis	0.000155	0.000511	CcSEcCtD
Bosentan—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000155	0.00051	CcSEcCtD
Bosentan—Syncope—Dexamethasone—ulcerative colitis	0.000155	0.00051	CcSEcCtD
Bosentan—Syncope—Betamethasone—ulcerative colitis	0.000155	0.00051	CcSEcCtD
Bosentan—Infection—Triamcinolone—ulcerative colitis	0.000154	0.000508	CcSEcCtD
Bosentan—Hypotension—Hydrocortisone—ulcerative colitis	0.000154	0.000507	CcSEcCtD
Bosentan—Infection—Methylprednisolone—ulcerative colitis	0.000154	0.000507	CcSEcCtD
Bosentan—Dizziness—Mesalazine—ulcerative colitis	0.000153	0.000505	CcSEcCtD
Bosentan—Shock—Triamcinolone—ulcerative colitis	0.000153	0.000503	CcSEcCtD
Bosentan—Insomnia—Prednisolone—ulcerative colitis	0.000153	0.000503	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—GHRL—ulcerative colitis	0.000152	0.00149	CbGpPWpGaD
Bosentan—Shock—Methylprednisolone—ulcerative colitis	0.000152	0.000502	CcSEcCtD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	0.000152	0.00149	CbGpPWpGaD
Bosentan—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000152	0.0005	CcSEcCtD
Bosentan—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000152	0.0005	CcSEcCtD
Bosentan—Loss of consciousness—Betamethasone—ulcerative colitis	0.000152	0.0005	CcSEcCtD
Bosentan—Paraesthesia—Prednisolone—ulcerative colitis	0.000152	0.000499	CcSEcCtD
Bosentan—Tachycardia—Triamcinolone—ulcerative colitis	0.000152	0.000499	CcSEcCtD
Bosentan—Mental disorder—Prednisone—ulcerative colitis	0.000151	0.000498	CcSEcCtD
Bosentan—Nausea—Azathioprine—ulcerative colitis	0.000151	0.000498	CcSEcCtD
Bosentan—Tachycardia—Methylprednisolone—ulcerative colitis	0.000151	0.000498	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—PTGER4—ulcerative colitis	0.000151	0.00148	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CXCR2—ulcerative colitis	0.000151	0.00147	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CXCL8—ulcerative colitis	0.000151	0.00147	CbGpPWpGaD
Bosentan—Skin disorder—Methylprednisolone—ulcerative colitis	0.00015	0.000496	CcSEcCtD
Bosentan—Malnutrition—Prednisone—ulcerative colitis	0.00015	0.000495	CcSEcCtD
Bosentan—Erythema—Prednisone—ulcerative colitis	0.00015	0.000495	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.00015	0.000495	CcSEcCtD
Bosentan—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.00015	0.000494	CcSEcCtD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.00015	0.00147	CbGpPWpGaD
Bosentan—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.00015	0.000493	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—ADCY5—ulcerative colitis	0.00015	0.00146	CbGpPWpGaD
Bosentan—Insomnia—Hydrocortisone—ulcerative colitis	0.000149	0.000491	CcSEcCtD
Bosentan—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000148	0.000488	CcSEcCtD
Bosentan—Vomiting—Mesalazine—ulcerative colitis	0.000147	0.000486	CcSEcCtD
Bosentan—Anxiety—Dexamethasone—ulcerative colitis	0.000146	0.000482	CcSEcCtD
Bosentan—Anxiety—Betamethasone—ulcerative colitis	0.000146	0.000482	CcSEcCtD
Bosentan—Rash—Mesalazine—ulcerative colitis	0.000146	0.000481	CcSEcCtD
Bosentan—Dermatitis—Mesalazine—ulcerative colitis	0.000146	0.000481	CcSEcCtD
Bosentan—Headache—Mesalazine—ulcerative colitis	0.000145	0.000478	CcSEcCtD
Bosentan—Discomfort—Betamethasone—ulcerative colitis	0.000145	0.000478	CcSEcCtD
Bosentan—Discomfort—Dexamethasone—ulcerative colitis	0.000145	0.000478	CcSEcCtD
Bosentan—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000145	0.000478	CcSEcCtD
Bosentan—Hypotension—Methylprednisolone—ulcerative colitis	0.000145	0.000477	CcSEcCtD
Bosentan—Pain—Prednisolone—ulcerative colitis	0.000144	0.000475	CcSEcCtD
Bosentan—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000143	0.000472	CcSEcCtD
Bosentan—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000142	0.000469	CcSEcCtD
Bosentan—Fatigue—Hydrocortisone—ulcerative colitis	0.000142	0.000468	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—CCR6—ulcerative colitis	0.000142	0.00139	CbGpPWpGaD
Bosentan—Vision blurred—Prednisone—ulcerative colitis	0.000142	0.000467	CcSEcCtD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000142	0.00138	CbGpPWpGaD
Bosentan—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000141	0.000466	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000141	0.000465	CcSEcCtD
Bosentan—Pain—Hydrocortisone—ulcerative colitis	0.000141	0.000464	CcSEcCtD
Bosentan—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000141	0.000464	CcSEcCtD
Bosentan—Oedema—Dexamethasone—ulcerative colitis	0.000141	0.000464	CcSEcCtD
Bosentan—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000141	0.000464	CcSEcCtD
Bosentan—Oedema—Betamethasone—ulcerative colitis	0.000141	0.000464	CcSEcCtD
Bosentan—Insomnia—Triamcinolone—ulcerative colitis	0.00014	0.000462	CcSEcCtD
Bosentan—ABCB11—Metabolism—DLD—ulcerative colitis	0.00014	0.00137	CbGpPWpGaD
Bosentan—Insomnia—Methylprednisolone—ulcerative colitis	0.00014	0.000461	CcSEcCtD
Bosentan—Infection—Dexamethasone—ulcerative colitis	0.00014	0.000461	CcSEcCtD
Bosentan—Infection—Betamethasone—ulcerative colitis	0.00014	0.000461	CcSEcCtD
Bosentan—Paraesthesia—Triamcinolone—ulcerative colitis	0.000139	0.000459	CcSEcCtD
Bosentan—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000139	0.000458	CcSEcCtD
Bosentan—Anaemia—Prednisone—ulcerative colitis	0.000139	0.000458	CcSEcCtD
Bosentan—Shock—Dexamethasone—ulcerative colitis	0.000139	0.000456	CcSEcCtD
Bosentan—Shock—Betamethasone—ulcerative colitis	0.000139	0.000456	CcSEcCtD
Bosentan—Dyspnoea—Triamcinolone—ulcerative colitis	0.000138	0.000456	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—GHRL—ulcerative colitis	0.000138	0.00135	CbGpPWpGaD
Bosentan—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000138	0.000455	CcSEcCtD
Bosentan—Nervous system disorder—Betamethasone—ulcerative colitis	0.000138	0.000455	CcSEcCtD
Bosentan—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000138	0.000454	CcSEcCtD
Bosentan—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000138	0.000454	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—CXCR1—ulcerative colitis	0.000138	0.00135	CbGpPWpGaD
Bosentan—Nausea—Mesalazine—ulcerative colitis	0.000138	0.000454	CcSEcCtD
Bosentan—Tachycardia—Dexamethasone—ulcerative colitis	0.000137	0.000453	CcSEcCtD
Bosentan—Tachycardia—Betamethasone—ulcerative colitis	0.000137	0.000453	CcSEcCtD
Bosentan—Angioedema—Prednisone—ulcerative colitis	0.000137	0.000452	CcSEcCtD
Bosentan—Dyspepsia—Triamcinolone—ulcerative colitis	0.000137	0.00045	CcSEcCtD
Bosentan—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000136	0.000449	CcSEcCtD
Bosentan—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000136	0.00133	CbGpPWpGaD
Bosentan—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000136	0.000448	CcSEcCtD
Bosentan—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000136	0.000448	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—ADCY5—ulcerative colitis	0.000136	0.00133	CbGpPWpGaD
Bosentan—Vertigo—Prednisone—ulcerative colitis	0.000135	0.000445	CcSEcCtD
Bosentan—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000135	0.000444	CcSEcCtD
Bosentan—Syncope—Prednisone—ulcerative colitis	0.000135	0.000444	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—MAML2—ulcerative colitis	0.000134	0.00131	CbGpPWpGaD
Bosentan—Anorexia—Betamethasone—ulcerative colitis	0.000134	0.000442	CcSEcCtD
Bosentan—Anorexia—Dexamethasone—ulcerative colitis	0.000134	0.000442	CcSEcCtD
Bosentan—Urticaria—Prednisolone—ulcerative colitis	0.000134	0.000442	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—CALM3—ulcerative colitis	0.000134	0.00131	CbGpPWpGaD
Bosentan—Fatigue—Triamcinolone—ulcerative colitis	0.000134	0.000441	CcSEcCtD
Bosentan—Fatigue—Methylprednisolone—ulcerative colitis	0.000134	0.00044	CcSEcCtD
Bosentan—Pain—Triamcinolone—ulcerative colitis	0.000133	0.000437	CcSEcCtD
Bosentan—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	0.000132	0.00129	CbGpPWpGaD
Bosentan—Loss of consciousness—Prednisone—ulcerative colitis	0.000132	0.000435	CcSEcCtD
Bosentan—Hypotension—Betamethasone—ulcerative colitis	0.000132	0.000434	CcSEcCtD
Bosentan—Hypotension—Dexamethasone—ulcerative colitis	0.000132	0.000434	CcSEcCtD
Bosentan—Urticaria—Hydrocortisone—ulcerative colitis	0.000131	0.000431	CcSEcCtD
Bosentan—Body temperature increased—Hydrocortisone—ulcerative colitis	0.00013	0.000429	CcSEcCtD
Bosentan—Abdominal pain—Hydrocortisone—ulcerative colitis	0.00013	0.000429	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000128	0.000423	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000128	0.000423	CcSEcCtD
Bosentan—Arthralgia—Prednisone—ulcerative colitis	0.000128	0.000421	CcSEcCtD
Bosentan—Anxiety—Prednisone—ulcerative colitis	0.000128	0.00042	CcSEcCtD
Bosentan—Insomnia—Betamethasone—ulcerative colitis	0.000127	0.00042	CcSEcCtD
Bosentan—Insomnia—Dexamethasone—ulcerative colitis	0.000127	0.00042	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000127	0.000419	CcSEcCtD
Bosentan—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000127	0.000417	CcSEcCtD
Bosentan—Paraesthesia—Betamethasone—ulcerative colitis	0.000126	0.000417	CcSEcCtD
Bosentan—Paraesthesia—Dexamethasone—ulcerative colitis	0.000126	0.000417	CcSEcCtD
Bosentan—Discomfort—Prednisone—ulcerative colitis	0.000126	0.000416	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000126	0.00123	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PTGER4—ulcerative colitis	0.000125	0.00122	CbGpPWpGaD
Bosentan—Hypersensitivity—Prednisolone—ulcerative colitis	0.000124	0.00041	CcSEcCtD
Bosentan—Dyspepsia—Dexamethasone—ulcerative colitis	0.000124	0.000408	CcSEcCtD
Bosentan—Dyspepsia—Betamethasone—ulcerative colitis	0.000124	0.000408	CcSEcCtD
Bosentan—Urticaria—Triamcinolone—ulcerative colitis	0.000123	0.000406	CcSEcCtD
Bosentan—Urticaria—Methylprednisolone—ulcerative colitis	0.000123	0.000405	CcSEcCtD
Bosentan—Body temperature increased—Triamcinolone—ulcerative colitis	0.000123	0.000404	CcSEcCtD
Bosentan—Anaphylactic shock—Prednisone—ulcerative colitis	0.000123	0.000404	CcSEcCtD
Bosentan—Oedema—Prednisone—ulcerative colitis	0.000123	0.000404	CcSEcCtD
Bosentan—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000122	0.000403	CcSEcCtD
Bosentan—Decreased appetite—Betamethasone—ulcerative colitis	0.000122	0.000403	CcSEcCtD
Bosentan—Decreased appetite—Dexamethasone—ulcerative colitis	0.000122	0.000403	CcSEcCtD
Bosentan—Infection—Prednisone—ulcerative colitis	0.000122	0.000401	CcSEcCtD
Bosentan—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000122	0.000401	CcSEcCtD
Bosentan—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000122	0.000401	CcSEcCtD
Bosentan—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000121	0.0004	CcSEcCtD
Bosentan—Fatigue—Dexamethasone—ulcerative colitis	0.000121	0.0004	CcSEcCtD
Bosentan—Fatigue—Betamethasone—ulcerative colitis	0.000121	0.0004	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—CCL20—ulcerative colitis	0.000121	0.00118	CbGpPWpGaD
Bosentan—Shock—Prednisone—ulcerative colitis	0.000121	0.000397	CcSEcCtD
Bosentan—Pain—Betamethasone—ulcerative colitis	0.00012	0.000397	CcSEcCtD
Bosentan—Pain—Dexamethasone—ulcerative colitis	0.00012	0.000397	CcSEcCtD
Bosentan—Nervous system disorder—Prednisone—ulcerative colitis	0.00012	0.000396	CcSEcCtD
Bosentan—Tachycardia—Prednisone—ulcerative colitis	0.00012	0.000394	CcSEcCtD
Bosentan—Skin disorder—Prednisone—ulcerative colitis	0.000119	0.000392	CcSEcCtD
Bosentan—Hyperhidrosis—Prednisone—ulcerative colitis	0.000119	0.000391	CcSEcCtD
Bosentan—Asthenia—Hydrocortisone—ulcerative colitis	0.000118	0.00039	CcSEcCtD
Bosentan—Anorexia—Prednisone—ulcerative colitis	0.000117	0.000385	CcSEcCtD
Bosentan—Pruritus—Hydrocortisone—ulcerative colitis	0.000117	0.000384	CcSEcCtD
Bosentan—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000115	0.000379	CcSEcCtD
Bosentan—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000115	0.000379	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—ADRB2—ulcerative colitis	0.000115	0.00112	CbGpPWpGaD
Bosentan—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000114	0.000377	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—GHRL—ulcerative colitis	0.000114	0.00112	CbGpPWpGaD
Bosentan—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000114	0.000376	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—GNA12—ulcerative colitis	0.000114	0.00111	CbGpPWpGaD
Bosentan—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000113	0.000372	CcSEcCtD
Bosentan—Urticaria—Betamethasone—ulcerative colitis	0.000112	0.000369	CcSEcCtD
Bosentan—Urticaria—Dexamethasone—ulcerative colitis	0.000112	0.000369	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000112	0.000368	CcSEcCtD
Bosentan—Dizziness—Prednisolone—ulcerative colitis	0.000112	0.000368	CcSEcCtD
Bosentan—Asthenia—Triamcinolone—ulcerative colitis	0.000111	0.000367	CcSEcCtD
Bosentan—Body temperature increased—Betamethasone—ulcerative colitis	0.000111	0.000367	CcSEcCtD
Bosentan—Body temperature increased—Dexamethasone—ulcerative colitis	0.000111	0.000367	CcSEcCtD
Bosentan—Abdominal pain—Dexamethasone—ulcerative colitis	0.000111	0.000367	CcSEcCtD
Bosentan—Abdominal pain—Betamethasone—ulcerative colitis	0.000111	0.000367	CcSEcCtD
Bosentan—Asthenia—Methylprednisolone—ulcerative colitis	0.000111	0.000366	CcSEcCtD
Bosentan—Insomnia—Prednisone—ulcerative colitis	0.000111	0.000365	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—CALM3—ulcerative colitis	0.000111	0.00108	CbGpPWpGaD
Bosentan—Paraesthesia—Prednisone—ulcerative colitis	0.00011	0.000363	CcSEcCtD
Bosentan—Pruritus—Triamcinolone—ulcerative colitis	0.00011	0.000362	CcSEcCtD
Bosentan—Pruritus—Methylprednisolone—ulcerative colitis	0.00011	0.000361	CcSEcCtD
Bosentan—Dizziness—Hydrocortisone—ulcerative colitis	0.000109	0.000359	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—RIPK2—ulcerative colitis	0.000109	0.00107	CbGpPWpGaD
Bosentan—Dyspepsia—Prednisone—ulcerative colitis	0.000108	0.000356	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—CXCR2—ulcerative colitis	0.000108	0.00106	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CXCL8—ulcerative colitis	0.000108	0.00105	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.000107	0.00105	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000107	0.00105	CbGpPWpGaD
Bosentan—Decreased appetite—Prednisone—ulcerative colitis	0.000107	0.000351	CcSEcCtD
Bosentan—Rash—Prednisolone—ulcerative colitis	0.000106	0.000351	CcSEcCtD
Bosentan—Dermatitis—Prednisolone—ulcerative colitis	0.000106	0.00035	CcSEcCtD
Bosentan—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000106	0.000349	CcSEcCtD
Bosentan—Fatigue—Prednisone—ulcerative colitis	0.000106	0.000348	CcSEcCtD
Bosentan—Headache—Prednisolone—ulcerative colitis	0.000106	0.000348	CcSEcCtD
Bosentan—Constipation—Prednisone—ulcerative colitis	0.000105	0.000345	CcSEcCtD
Bosentan—Vomiting—Hydrocortisone—ulcerative colitis	0.000105	0.000345	CcSEcCtD
Bosentan—Rash—Hydrocortisone—ulcerative colitis	0.000104	0.000342	CcSEcCtD
Bosentan—Dermatitis—Hydrocortisone—ulcerative colitis	0.000104	0.000342	CcSEcCtD
Bosentan—Headache—Hydrocortisone—ulcerative colitis	0.000103	0.00034	CcSEcCtD
Bosentan—Dizziness—Triamcinolone—ulcerative colitis	0.000103	0.000338	CcSEcCtD
Bosentan—Dizziness—Methylprednisolone—ulcerative colitis	0.000102	0.000337	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—CCR6—ulcerative colitis	0.000101	0.000992	CbGpPWpGaD
Bosentan—Asthenia—Dexamethasone—ulcerative colitis	0.000101	0.000333	CcSEcCtD
Bosentan—Asthenia—Betamethasone—ulcerative colitis	0.000101	0.000333	CcSEcCtD
Bosentan—Gastrointestinal pain—Prednisone—ulcerative colitis	0.0001	0.00033	CcSEcCtD
Bosentan—Nausea—Prednisolone—ulcerative colitis	0.0001	0.00033	CcSEcCtD
Bosentan—Pruritus—Betamethasone—ulcerative colitis	9.97e-05	0.000328	CcSEcCtD
Bosentan—Pruritus—Dexamethasone—ulcerative colitis	9.97e-05	0.000328	CcSEcCtD
Bosentan—Vomiting—Triamcinolone—ulcerative colitis	9.87e-05	0.000325	CcSEcCtD
Bosentan—Vomiting—Methylprednisolone—ulcerative colitis	9.85e-05	0.000324	CcSEcCtD
Bosentan—Nausea—Hydrocortisone—ulcerative colitis	9.79e-05	0.000323	CcSEcCtD
Bosentan—Rash—Triamcinolone—ulcerative colitis	9.79e-05	0.000322	CcSEcCtD
Bosentan—Dermatitis—Triamcinolone—ulcerative colitis	9.78e-05	0.000322	CcSEcCtD
Bosentan—Rash—Methylprednisolone—ulcerative colitis	9.77e-05	0.000322	CcSEcCtD
Bosentan—Dermatitis—Methylprednisolone—ulcerative colitis	9.76e-05	0.000321	CcSEcCtD
Bosentan—Urticaria—Prednisone—ulcerative colitis	9.74e-05	0.000321	CcSEcCtD
Bosentan—Headache—Triamcinolone—ulcerative colitis	9.72e-05	0.00032	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—ADCY5—ulcerative colitis	9.72e-05	0.000951	CbGpPWpGaD
Bosentan—Headache—Methylprednisolone—ulcerative colitis	9.7e-05	0.00032	CcSEcCtD
Bosentan—Body temperature increased—Prednisone—ulcerative colitis	9.7e-05	0.000319	CcSEcCtD
Bosentan—Abdominal pain—Prednisone—ulcerative colitis	9.7e-05	0.000319	CcSEcCtD
Bosentan—Diarrhoea—Dexamethasone—ulcerative colitis	9.64e-05	0.000317	CcSEcCtD
Bosentan—Diarrhoea—Betamethasone—ulcerative colitis	9.64e-05	0.000317	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—MAML2—ulcerative colitis	9.61e-05	0.000941	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—ADRB2—ulcerative colitis	9.45e-05	0.000925	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—JAK2—ulcerative colitis	9.33e-05	0.000912	CbGpPWpGaD
Bosentan—Dizziness—Betamethasone—ulcerative colitis	9.31e-05	0.000307	CcSEcCtD
Bosentan—Dizziness—Dexamethasone—ulcerative colitis	9.31e-05	0.000307	CcSEcCtD
Bosentan—Nausea—Triamcinolone—ulcerative colitis	9.22e-05	0.000304	CcSEcCtD
Bosentan—Nausea—Methylprednisolone—ulcerative colitis	9.2e-05	0.000303	CcSEcCtD
Bosentan—Hypersensitivity—Prednisone—ulcerative colitis	9.04e-05	0.000298	CcSEcCtD
Bosentan—Vomiting—Dexamethasone—ulcerative colitis	8.96e-05	0.000295	CcSEcCtD
Bosentan—Vomiting—Betamethasone—ulcerative colitis	8.96e-05	0.000295	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—PTGER4—ulcerative colitis	8.93e-05	0.000874	CbGpPWpGaD
Bosentan—Rash—Betamethasone—ulcerative colitis	8.88e-05	0.000293	CcSEcCtD
Bosentan—Rash—Dexamethasone—ulcerative colitis	8.88e-05	0.000293	CcSEcCtD
Bosentan—Dermatitis—Betamethasone—ulcerative colitis	8.87e-05	0.000292	CcSEcCtD
Bosentan—Dermatitis—Dexamethasone—ulcerative colitis	8.87e-05	0.000292	CcSEcCtD
Bosentan—Headache—Betamethasone—ulcerative colitis	8.82e-05	0.000291	CcSEcCtD
Bosentan—Headache—Dexamethasone—ulcerative colitis	8.82e-05	0.000291	CcSEcCtD
Bosentan—Asthenia—Prednisone—ulcerative colitis	8.8e-05	0.00029	CcSEcCtD
Bosentan—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	8.73e-05	0.000854	CbGpPWpGaD
Bosentan—Pruritus—Prednisone—ulcerative colitis	8.68e-05	0.000286	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—CXCL8—ulcerative colitis	8.51e-05	0.000833	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—JAK2—ulcerative colitis	8.47e-05	0.000829	CbGpPWpGaD
Bosentan—Diarrhoea—Prednisone—ulcerative colitis	8.39e-05	0.000276	CcSEcCtD
Bosentan—Nausea—Betamethasone—ulcerative colitis	8.37e-05	0.000276	CcSEcCtD
Bosentan—Nausea—Dexamethasone—ulcerative colitis	8.37e-05	0.000276	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—GHRL—ulcerative colitis	8.17e-05	0.0008	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—IL2—ulcerative colitis	8.13e-05	0.000796	CbGpPWpGaD
Bosentan—Dizziness—Prednisone—ulcerative colitis	8.11e-05	0.000267	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—ADCY5—ulcerative colitis	8.03e-05	0.000785	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CALM3—ulcerative colitis	7.92e-05	0.000775	CbGpPWpGaD
Bosentan—Vomiting—Prednisone—ulcerative colitis	7.8e-05	0.000257	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—RIPK2—ulcerative colitis	7.8e-05	0.000763	CbGpPWpGaD
Bosentan—Rash—Prednisone—ulcerative colitis	7.73e-05	0.000255	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—CXCL8—ulcerative colitis	7.73e-05	0.000756	CbGpPWpGaD
Bosentan—Dermatitis—Prednisone—ulcerative colitis	7.73e-05	0.000255	CcSEcCtD
Bosentan—Headache—Prednisone—ulcerative colitis	7.68e-05	0.000253	CcSEcCtD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.41e-05	0.000725	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL2—ulcerative colitis	7.39e-05	0.000723	CbGpPWpGaD
Bosentan—Nausea—Prednisone—ulcerative colitis	7.29e-05	0.00024	CcSEcCtD
Bosentan—ABCB11—Metabolism—PTGS1—ulcerative colitis	6.78e-05	0.000663	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ADRB2—ulcerative colitis	6.77e-05	0.000662	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—JAK2—ulcerative colitis	6.68e-05	0.000653	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.67e-05	0.000652	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CALM3—ulcerative colitis	6.1e-05	0.000597	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CXCL8—ulcerative colitis	6.09e-05	0.000596	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—JAK2—ulcerative colitis	6.06e-05	0.000593	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.83e-05	0.00057	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—IL2—ulcerative colitis	5.82e-05	0.00057	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ADCY5—ulcerative colitis	5.74e-05	0.000562	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CXCL8—ulcerative colitis	5.53e-05	0.000541	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CHP1—ulcerative colitis	5.42e-05	0.00053	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL2—ulcerative colitis	5.29e-05	0.000517	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	5.08e-05	0.000497	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—JAK2—ulcerative colitis	5e-05	0.000489	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—RELA—ulcerative colitis	4.85e-05	0.000474	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ABCB1—ulcerative colitis	4.74e-05	0.000464	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—DLD—ulcerative colitis	4.68e-05	0.000458	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CXCL8—ulcerative colitis	4.57e-05	0.000447	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ADCY5—ulcerative colitis	4.43e-05	0.000433	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL2—ulcerative colitis	4.36e-05	0.000427	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL6—ulcerative colitis	4.34e-05	0.000425	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MMP9—ulcerative colitis	4.13e-05	0.000404	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NFKB1—ulcerative colitis	4.09e-05	0.0004	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—STAT3—ulcerative colitis	3.67e-05	0.000359	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—JAK2—ulcerative colitis	3.58e-05	0.00035	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CHP1—ulcerative colitis	3.58e-05	0.00035	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—RELA—ulcerative colitis	3.47e-05	0.000339	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TGFB1—ulcerative colitis	3.4e-05	0.000333	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PPARG—ulcerative colitis	3.3e-05	0.000323	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCL8—ulcerative colitis	3.27e-05	0.00032	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL2—ulcerative colitis	3.12e-05	0.000306	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL6—ulcerative colitis	3.11e-05	0.000304	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—DLD—ulcerative colitis	3.09e-05	0.000302	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALB—ulcerative colitis	2.97e-05	0.00029	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MMP9—ulcerative colitis	2.96e-05	0.000289	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NFKB1—ulcerative colitis	2.92e-05	0.000286	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TP53—ulcerative colitis	2.8e-05	0.000274	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—STAT3—ulcerative colitis	2.63e-05	0.000257	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PTGS2—ulcerative colitis	2.6e-05	0.000254	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL6—ulcerative colitis	2.57e-05	0.000251	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.47e-05	0.000242	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TGFB1—ulcerative colitis	2.44e-05	0.000238	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PTGS1—ulcerative colitis	2.26e-05	0.000221	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.23e-05	0.000218	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CALM3—ulcerative colitis	2.04e-05	0.000199	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TP53—ulcerative colitis	2.01e-05	0.000196	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.95e-05	0.00019	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL6—ulcerative colitis	1.84e-05	0.00018	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ABCB1—ulcerative colitis	1.58e-05	0.000155	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.49e-05	0.000146	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ADCY5—ulcerative colitis	1.48e-05	0.000145	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.34e-05	0.000131	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPARG—ulcerative colitis	1.1e-05	0.000108	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.04e-05	0.000102	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALB—ulcerative colitis	9.91e-06	9.7e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ADCY5—ulcerative colitis	9.75e-06	9.54e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PTGS2—ulcerative colitis	8.67e-06	8.48e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPARG—ulcerative colitis	7.27e-06	7.11e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALB—ulcerative colitis	6.54e-06	6.39e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PTGS2—ulcerative colitis	5.72e-06	5.59e-05	CbGpPWpGaD
